Lupin files BLA for biosimilar etanercept (YBL113) in Japan

May 8, 2018

Lupin announced YL Biologics has filed a BLA for biosimilar etanercept (YBL113) in Japan. YL Biologics is a joint venture between Yoshindo and Kyowa (Lupin’s subsidiary), and YBL113 is the first biosimilar developed by the JV.

Print Page Mail Article